|
|
Article: Study examines role of insulin resistance in predicting cardiovascular disease.
- Article from:
- Pharma Business Week
- Article date:
- September 27, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 SEP 27 - (NewsRx.com & NewsRx.net) -- The European Group for the study of Insulin Resistance (EGIR) announced that the clinical trial recruitment milestone of 1,200 subjects has been reached in the Relationship between Insulin Sensitivity and Cardiovascular disease risk (RISC) study.
RISC is the largest study using the euglycaemic clamp technique to date to examine whether insulin resistance predicts cardiovascular disease (CVD), as well as future development of type 2 diabetes. This study, cosponsored by the European Union (E.U.) and AstraZeneca, began in February 2002, involves 14 European countries and is expected to publish initial results by 2005.
...